Bevacizumab
#
Find similar titles
- (rev. 1)
- Hyungyong Kim
Structured data
- Drug Class
- Angiogenesis inhibitor
- URL
- https://en.wikipedia.org/wiki/Bevacizumab
Bevacizumab, sold under the trade name Avastin, is an Angiogenesis inhibitor, a drug that slows the growth of new blood vessels. Bevacizumab is a recombinant humanized Monoclonal antibody that blocks Angiogenesis by inhibiting VEGF. (https://en.wikipedia.org/wiki/Bevacizumab)
Targets
Incoming Links #
Related Articles (Article 0) #
Related Medical Scholarly Articles (MedicalScholarlyArticle 1) #
Suggested Pages #
- 0.149 BCL11A is a triple-negative breast cancer gene with critical functions in stem and progenitor cells
- 0.109 Next generation sequencing of triple negative breast cancer to find predictors for chemotherapy response
- 0.049 CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer
- 0.043 Triple-negative breast cancer: an unmet medical need
- 0.025 Cancer
- 0.025 Vasculogenesis
- 0.025 May 29
- 0.025 Pituitary adenomas
- 0.025 Buparlisib
- 0.025 Vascular endothelial growth factor
- More suggestions...